Laurus Labs Ltd
NSE: LAURUSLABS BSE: 540222
₹1075.80
(-1.55%)
Sat, 07 Mar 2026, 02:21 pm
Market Cap580.21B
PE Ratio68.91
Dividend0.15
Health Technology
Pharmaceuticals: Major
24.5KLaurus Labs Income Statement
| Particulars | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.56B | 13.14B | 17.61B | 18.87B | 20.29B | 22.65B | 27.87B | 47.81B | 49.35B | 60.40B | 50.41B | 55.54B |
| Gross profit | 2.47B | 2.10B | 4.66B | 4.76B | 4.38B | 3.24B | 5.20B | 15.51B | 14.38B | 15.85B | 7.21B | 10.84B |
| Operating expenses (excl. COGS) | -711.38M | -808.58M | -1.85B | -1.82B | -1.68B | -1.43B | -1.80B | -2.30B | -2.50B | -2.71B | -3.01B | -4.30B |
| Selling/general/admin expenses, total | -707.39M | -818.55M | -2.00B | -1.81B | -1.64B | -1.10B | -1.67B | -1.95B | -2.17B | -2.37B | -2.69B | -3.89B |
| Research & development | -349.87M | -453.63M | -1.49B | -1.15B | -1.06B | -131.51M | -151.77M | -1.79B | -1.84B | -1.85B | -2.04B | -2.42B |
| Selling/general/admin expenses, other | -357.52M | -364.92M | -512.40M | -656.33M | -577.27M | -965.60M | -1.52B | -165.70M | -334.50M | -525.90M | -651.10M | -1.47B |
| Other operating expenses, total | -3.99M | 9.97M | 143.77M | -15.53M | -36.71M | -333.81M | -130.61M | -342.00M | -328.00M | -342.00M | -318.10M | -407.30M |
| Operating income | 1.76B | 1.29B | 2.81B | 2.94B | 2.71B | 1.81B | 3.40B | 13.22B | 11.88B | 13.14B | 4.19B | 6.54B |
| Non-operating income, total | -521.94M | -626.54M | -1.12B | -587.96M | -335.05M | -614.63M | -460.33M | -205.40M | -1.04B | -2.05B | -1.83B | -1.69B |
| Interest expense, net of interest capitalized | -576.38M | -960.59M | -1.11B | -969.91M | -729.32M | -766.59M | -785.97M | -663.80M | -919.60M | -1.43B | -1.80B | -2.13B |
| Interest capitalized | 0 | 0 | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 42.40M |
| Non-operating income, excl. interest expenses | 54.44M | 219.37M | -6.46M | 381.95M | 394.27M | 151.96M | 325.64M | 458.40M | -124.40M | -623.90M | -205.10M | 431.80M |
| Non-operating interest income | 34.89M | 21.69M | 24.34M | 15.05M | 7.62M | 8.88M | 9.71M | 13.10M | 17.20M | 45.60M | 56.10M | 151.70M |
| Miscellaneous non-operating expense | 19.55M | 197.68M | -30.80M | 366.90M | 386.65M | 143.08M | 315.93M | 445.30M | -141.60M | -669.50M | -261.20M | 280.10M |
| Unusual income/expense | — | 114.68M | — | — | — | — | 0 | 0 | 0 | 0 | 170.50M | 0 |
| Pretax income | 1.24B | 666.42M | 1.69B | 2.35B | 2.37B | 1.20B | 2.94B | 13.01B | 10.84B | 11.09B | 2.36B | 4.84B |
| Taxes | -246.46M | 15.26M | -349.03M | -438.64M | -698.06M | -259.88M | -383.38M | -3.17B | -2.51B | -3.12B | -681.50M | -1.30B |
| Non-controlling/minority interest | 0 | — | 0 | 0 | 0 | 0 | 0 | -2.40M | -47.10M | -33.20M | -17.20M | -200.00K |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 991.21M | 684.17M | 1.34B | 1.90B | 1.68B | 937.64M | 2.55B | 9.84B | 8.28B | 7.90B | 1.61B | 3.58B |
| Net income | 991.21M | 684.17M | 1.34B | 1.90B | 1.68B | 937.64M | 2.55B | 9.84B | 8.28B | 7.90B | 1.61B | 3.58B |
| Dilution adjustment | 10.00K | 10.00K | 0 | 21.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 10.00K | 10.00K | 0 | 21.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 991.21M | 684.17M | 1.34B | 1.90B | 1.68B | 937.64M | 2.55B | 9.84B | 8.28B | 7.90B | 1.61B | 3.58B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 2.09B | 1.91B | 3.67B | 4.00B | 3.96B | 3.45B | 5.27B | 15.27B | 14.40B | 16.38B | 8.04B | 10.84B |
| EBIT | 1.76B | 1.29B | 2.81B | 2.94B | 2.71B | 1.81B | 3.40B | 13.22B | 11.88B | 13.14B | 4.19B | 6.54B |
| Total operating expenses | -9.80B | -11.85B | -14.81B | -15.93B | -17.58B | -20.84B | -24.47B | -34.59B | -37.47B | -47.26B | -46.21B | -49.00B |
| Prepaid expenses | 51.99M | 84.32M | 64.03M | 75.37M | 97.92M | 117.23M | 117.56M | 164.50M | 166.40M | 204.50M | 280.50M | 292.80M |
| Deferred income, current | 626.57M | 54.73M | 124.39M | 475.10M | 742.90M | 689.07M | 712.32M | 869.80M | 2.44B | 1.48B | 818.50M | 475.90M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 205.59M | 262.70M | 396.30M | 374.40M | 621.60M | 621.90M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 273.60M | 490.28M | 630.39M | 1.01B | 1.19B | 1.37B | 1.44B | 1.44B | 1.56B | 1.30B | 1.43B | 1.51B |
| Deferred income, non-current | — | — | — | 630.72M | 646.97M | 601.16M | 567.42M | 718.40M | 670.30M | 1.25B | 1.06B | 3.48B |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31.50M | 78.60M | 111.30M | 46.20M | 1.30B |
| Change in accrued expenses | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | -59.39M | -190.93M | -191.73M | -385.81M | -750.40M | -858.60M | -1.07B | -861.80M | -431.30M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800